Published in Am J Hum Genet on April 26, 2007
Personalized copy number and segmental duplication maps using next-generation sequencing. Nat Genet (2009) 11.73
Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet (2007) 8.07
Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet (2009) 7.64
The fine-scale and complex architecture of human copy-number variation. Am J Hum Genet (2008) 5.08
A robust statistical method for case-control association testing with copy number variation. Nat Genet (2008) 4.78
Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat Rev Genet (2009) 2.46
Estimating the human mutation rate using autozygosity in a founder population. Nat Genet (2012) 2.44
Copy number variants and common disorders: filling the gaps and exploring complexity in genome-wide association studies. PLoS Genet (2007) 2.32
Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc Natl Acad Sci U S A (2009) 2.31
Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol (2010) 2.18
Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med (2008) 2.13
The functional impact of structural variation in humans. Trends Genet (2008) 2.03
Analysis of copy number variations among diverse cattle breeds. Genome Res (2010) 2.02
Gene copy-number alterations: a cost-benefit analysis. Cell (2013) 1.79
Genetic association analysis of copy-number variation (CNV) in human disease pathogenesis. Genomics (2008) 1.76
Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev (2010) 1.70
Human MHC architecture and evolution: implications for disease association studies. Int J Immunogenet (2008) 1.70
Mapping DNA structural variation in dogs. Genome Res (2008) 1.64
CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus. Ann Rheum Dis (2007) 1.62
Copy number variation of individual cattle genomes using next-generation sequencing. Genome Res (2012) 1.62
Identification of two independent risk factors for lupus within the MHC in United Kingdom families. PLoS Genet (2007) 1.51
Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet (2011) 1.49
The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action. Curr Genomics (2007) 1.47
Analysis of immune regulatory genes' copy number variants in Graves' disease. Thyroid (2010) 1.47
Copy number variation of the APC gene is associated with regulation of bone mineral density. Bone (2012) 1.46
Association between C4, C4A, and C4B copy number variations and susceptibility to autoimmune diseases: a meta-analysis. Sci Rep (2017) 1.39
Phenotypic consequences of copy number variation: insights from Smith-Magenis and Potocki-Lupski syndrome mouse models. PLoS Biol (2010) 1.36
Allelic recombination between distinct genomic locations generates copy number diversity in human beta-defensins. Proc Natl Acad Sci U S A (2009) 1.33
Rheumatoid arthritis: a view of the current genetic landscape. Genes Immun (2008) 1.32
Selective IgA deficiency in autoimmune diseases. Mol Med (2011) 1.31
The search for lupus biomarkers. Best Pract Res Clin Rheumatol (2009) 1.26
Genetics of type 1 diabetes. Cold Spring Harb Perspect Med (2012) 1.25
Genetic variation and the de novo assembly of human genomes. Nat Rev Genet (2015) 1.24
Recent advances in asthma genetics. Respir Res (2008) 1.23
The lupus family registry and repository. Rheumatology (Oxford) (2010) 1.21
The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus (2010) 1.21
Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex. Hum Mol Genet (2009) 1.21
Current status on Alzheimer disease molecular genetics: from past, to present, to future. Hum Mol Genet (2010) 1.20
The contribution of genetic variation and infection to the pathogenesis of ANCA-associated systemic vasculitis. Arthritis Res Ther (2010) 1.20
Copy number variation in the human genome and its implication in autoimmunity. Clin Exp Immunol (2009) 1.14
Human genes involved in copy number variation: mechanisms of origin, functional effects and implications for disease. Cytogenet Genome Res (2009) 1.13
Determination of beta-defensin genomic copy number in different populations: a comparison of three methods. PLoS One (2011) 1.12
Monocyte and macrophage abnormalities in systemic lupus erythematosus. Arch Immunol Ther Exp (Warsz) (2010) 1.12
A novel mechanistic spectrum underlies glaucoma-associated chromosome 6p25 copy number variation. Hum Mol Genet (2008) 1.09
Identification of copy number variation hotspots in human populations. Am J Hum Genet (2010) 1.08
Molecular basis of complete complement C4 deficiency in two North-African families with systemic lupus erythematosus. Genes Immun (2009) 1.07
Great genotypic and phenotypic diversities associated with copy-number variations of complement C4 and RP-C4-CYP21-TNX (RCCX) modules: a comparison of Asian-Indian and European American populations. Mol Immunol (2009) 1.07
Novel origins of copy number variation in the dog genome. Genome Biol (2012) 1.06
Digital genotyping of macrosatellites and multicopy genes reveals novel biological functions associated with copy number variation of large tandem repeats. PLoS Genet (2014) 1.06
Genome-wide detection of copy number variations using high-density SNP genotyping platforms in Holsteins. BMC Genomics (2013) 1.06
Genetics of immunological and inflammatory components in age-related macular degeneration. Ocul Immunol Inflamm (2012) 1.04
Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res (2009) 1.03
Statistical issues in the analysis of DNA Copy Number Variations. Int J Comput Biol Drug Des (2008) 1.02
Copy number variation in the domestic dog. Mamm Genome (2011) 1.01
Pathways: Strategies for susceptibility genes in SLE. Autoimmun Rev (2010) 1.01
Computing power and sample size for case-control association studies with copy number polymorphism: application of mixture-based likelihood ratio test. PLoS One (2008) 1.01
D-dimer level and the risk for thrombosis in systemic lupus erythematosus. Clin J Am Soc Nephrol (2008) 1.00
Cutting edge: the etiology of autoimmune thyroid diseases. Clin Rev Allergy Immunol (2011) 1.00
Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis. Semin Nephrol (2010) 0.99
Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus. Eur J Hum Genet (2010) 0.98
Copy number variants in genetic susceptibility and severity of systemic lupus erythematosus. Cytogenet Genome Res (2009) 0.98
Assessment of complement C4 gene copy number using the paralog ratio test. Hum Mutat (2010) 0.97
Human gene copy number variation and infectious disease. Hum Genet (2014) 0.97
Improved detection of global copy number variation using high density, non-polymorphic oligonucleotide probes. BMC Genet (2008) 0.96
Gene-function studies in systemic lupus erythematosus. Nat Rev Rheumatol (2013) 0.96
Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease. Clin Exp Immunol (2010) 0.95
What epidemiology has told us about risk factors and aetiopathogenesis in rheumatic diseases. Arthritis Res Ther (2009) 0.93
Copy number variation in the cattle genome. Funct Integr Genomics (2012) 0.92
Genetics of rheumatic disease. Arthritis Res Ther (2009) 0.91
Homozygous deletion of the UGT2B17 gene is not associated with osteoporosis risk in elderly Caucasian women. Osteoporos Int (2010) 0.91
FCGR3B copy number variation is associated with systemic lupus erythematosus risk in Afro-Caribbeans. Rheumatology (Oxford) (2011) 0.90
Genetic variation of the Fc gamma receptor 3B gene and association with rheumatoid arthritis. PLoS One (2010) 0.90
Copy number variation in the complement factor H-related genes and age-related macular degeneration. Mol Vis (2011) 0.90
The evolutionary significance of copy number variation in the human genome. Cytogenet Genome Res (2009) 0.89
Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases. Front Immunol (2016) 0.88
A pilot study on collective effects of 22q13.31 deletions on gray matter concentration in schizophrenia. PLoS One (2012) 0.88
Whole-genome sequencing of individuals from a founder population identifies candidate genes for asthma. PLoS One (2014) 0.88
Detection of copy number variants reveals association of cilia genes with neural tube defects. PLoS One (2013) 0.87
Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations. Am J Hum Genet (2012) 0.87
Defining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing. Am J Hum Genet (2016) 0.87
A diverse array of genetic factors contribute to the pathogenesis of systemic lupus erythematosus. Orphanet J Rare Dis (2013) 0.87
Genotypic diversity of complement component C4 does not predict kidney transplant outcome. J Am Soc Nephrol (2010) 0.86
Current challenges in the bioinformatics of single cell genomics. Front Oncol (2014) 0.86
Effect of homozygous deletions at 22q13.1 on alcohol dependence severity and cue-elicited BOLD response in the precuneus. Addict Biol (2011) 0.86
Increased frequency of complement C4B deficiency in rheumatoid arthritis. Arthritis Rheum (2012) 0.86
Sex Differences in monocytes and TLR4 associated immune responses; implications for systemic lupus erythematosus (SLE). J Immunother Appl (2014) 0.84
Association between copy number variation of complement component C4 and Graves' disease. J Biomed Sci (2011) 0.84
Copy number variation prevalence in known asthma genes and their impact on asthma susceptibility. Clin Exp Allergy (2013) 0.84
A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum. Endocr Relat Cancer (2011) 0.84
Genome-wide copy number variant analysis in inbred chickens lines with different susceptibility to Marek's disease. G3 (Bethesda) (2013) 0.83
PAIR: paired allelic log-intensity-ratio-based normalization method for SNP-CGH arrays. Bioinformatics (2012) 0.83
Accurate measurement of gene copy number for human alpha-defensin DEFA1A3. BMC Genomics (2013) 0.83
Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus. Clin Dev Immunol (2012) 0.83
A 129-kb deletion on chromosome 12 confers substantial protection against rheumatoid arthritis, implicating the gene SLC2A3. Hum Mutat (2013) 0.82
Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway. Front Immunol (2016) 0.82
Genetics of SLE: functional relevance for monocytes/macrophages in disease. Clin Dev Immunol (2012) 0.81
Determination of the loss of function complement C4 exon 29 CT insertion using a novel paralog-specific assay in healthy UK and Spanish populations. PLoS One (2011) 0.81
Copy number variations burden on miRNA genes reveals layers of complexities involved in the regulation of pathways and phenotypic expression. PLoS One (2014) 0.81
Complement 4 phenotypes and genotypes in Brazilian patients with classical 21-hydroxylase deficiency. Clin Exp Immunol (2009) 0.81
Confirmation of C4 gene copy number variation and the association with systemic lupus erythematosus in Chinese Han population. Rheumatol Int (2011) 0.81
A haplotype map of the human genome. Nature (2005) 105.70
The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1982) 67.54
Global variation in copy number in the human genome. Nature (2006) 57.50
Detection of large-scale variation in the human genome. Nat Genet (2004) 49.18
Large-scale copy number polymorphism in the human genome. Science (2004) 34.64
Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science (2007) 23.38
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science (2005) 17.00
A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet (2006) 15.63
Complete MHC haplotype sequencing for common disease gene mapping. Genome Res (2004) 12.09
Complement. First of two parts. N Engl J Med (2001) 11.16
Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature (2006) 9.30
A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet (2006) 8.61
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet (1998) 8.20
Complement. Second of two parts. N Engl J Med (2001) 6.32
Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med (1968) 5.95
Complex SNP-related sequence variation in segmental genome duplications. Nat Genet (2004) 5.90
A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet (2006) 5.10
The sex-specific genetic architecture of quantitative traits in humans. Nat Genet (2006) 4.93
Family-based designs in the age of large-scale gene-association studies. Nat Rev Genet (2006) 4.59
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev (2000) 3.99
Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci U S A (1980) 3.97
Autoimmune diseases. N Engl J Med (2001) 3.60
Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc Natl Acad Sci U S A (1985) 3.22
Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A (1990) 2.88
Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J (Clin Res Ed) (1983) 2.86
A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet (2005) 2.85
Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history. PLoS Genet (2006) 2.80
Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci U S A (1986) 2.68
The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol (2004) 2.67
A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med (2001) 2.50
The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol (1998) 2.50
The genetic architecture of quantitative traits: lessons from Drosophila. Curr Opin Genet Dev (2004) 2.49
Inherited deficiency of the second component of complement. Rheumatic disease associations. J Clin Invest (1976) 2.38
Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man. Proc Natl Acad Sci U S A (1983) 2.23
A comparison of the properties of two classes, C4A and C4B, of the human complement component C4. EMBO J (1984) 2.22
Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Arthritis Rheum (2004) 2.16
The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4. J Immunol (1984) 2.14
Phenotyping of human complement component C4, a class-III HLA antigen. Biochem J (1986) 2.10
Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet (2002) 1.93
A critical role for complement in maintenance of self-tolerance. Immunity (1998) 1.90
Invited anniversary review: HLA associated diseases. Hum Immunol (1997) 1.70
Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol Rev (1999) 1.65
Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity. EMBO J (1986) 1.54
Meta-analysis of genome-wide linkage studies of systemic lupus erythematosus. Genes Immun (2006) 1.54
The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific genomic patterns among Old World primates. Immunogenetics (1994) 1.52
Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J Exp Med (2000) 1.51
Genetic sophistication of human complement components C4A and C4B and RP-C4-CYP21-TNX (RCCX) modules in the major histocompatibility complex. Am J Hum Genet (2002) 1.47
Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol (2001) 1.47
Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis. Hum Genet (2005) 1.44
The reaction mechanism of the internal thioester in the human complement component C4. Nature (1996) 1.35
The genetics of human systemic lupus erythematosus. Trends Immunol (2003) 1.34
Polymorphism of human complement component C4. Immunogenetics (1985) 1.28
Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat Clin Pract Rheumatol (2006) 1.28
Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet (2006) 1.25
Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities, and body mass index. J Immunol (2003) 1.24
Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4. Int Immunopharmacol (2001) 1.23
Complement deficiencies in humans and animals: links to autoimmunity. Autoimmunity (2006) 1.22
Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A. Proc Natl Acad Sci U S A (1990) 1.17
Genetics of susceptibility and severity in systemic lupus erythematosus. Curr Opin Rheumatol (2005) 1.15
The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun (2004) 1.15
Human genome: patchwork people. Nature (2005) 1.12
Mechanism and consequences of the duplication of the human C4/P450c21/gene X locus. Mol Cell Biol (1992) 1.10
Determining the one, two, three, or four long and short loci of human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins. Am J Hum Genet (2002) 1.09
The complete exon-intron structure of a human complement component C4A gene. DNA sequences, polymorphism, and linkage to the 21-hydroxylase gene. J Immunol (1991) 1.06
A structural model for the location of the Rodgers and the Chido antigenic determinants and their correlation with the human complement component C4A/C4B isotypes. Immunogenetics (1988) 1.06
Analysis of the association of HLA-DRB1, TNFalpha promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test. Genes Immun (2001) 1.04
The origin of the very variable haemolytic activities of the common human complement component C4 allotypes including C4-A6. EMBO J (1985) 1.03
Reference typing report for complement component C4. Exp Clin Immunogenet (1998) 1.01
Complement testing in the diagnosis of immune and autoimmune diseases. Am J Clin Pathol (1977) 0.98
Lupus erythematosus syndrome and complete deficiency of the fourth component of complement. Boll Ist Sieroter Milan (1974) 0.96
Dancing with complement C4 and the RP-C4-CYP21-TNX (RCCX) modules of the major histocompatibility complex. Prog Nucleic Acid Res Mol Biol (2003) 0.96
Sex, MHC and complement C4 in autoimmune diseases. Trends Immunol (2004) 0.95
The endogenous retroviral insertion in the human complement C4 gene modulates the expression of homologous genes by antisense inhibition. Immunogenetics (2001) 0.94
Relationship between complement components C4A and C4B diversities and two TNFA promoter polymorphisms in two healthy Caucasian populations. Hum Immunol (2003) 0.85
Genetics: copies count. Nature (2006) 0.84
Three distinct profiles of serum complement C4 proteins in pediatric systemic lupus erythematosus (SLE) patients: tight associations of complement C4 and C3 protein levels in SLE but not in healthy subjects. Adv Exp Med Biol (2006) 0.84
Combined heterozygous deficiency of the classical complement pathway proteins C2 and C4. J Clin Immunol (1997) 0.81
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science (2005) 17.00
Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet (2008) 12.51
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken) (2012) 6.51
Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int (2011) 4.51
Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med (2002) 3.83
DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. Elife (2013) 2.67
Management of glomerular proteinuria: a commentary. J Am Soc Nephrol (2003) 2.59
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat Genet (2011) 2.54
Typing of amyloidosis in renal biopsies: diagnostic pitfalls. Arch Pathol Lab Med (2007) 2.50
Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum (2006) 2.50
Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol (2004) 2.49
Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum (2004) 2.31
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A (2002) 2.31
Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol (2010) 2.18
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol (2014) 1.95
Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet (2011) 1.92
Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am J Physiol Heart Circ Physiol (2005) 1.90
Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res (Hoboken) (2012) 1.84
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum (2011) 1.79
Association of a functional IRF7 variant with systemic lupus erythematosus. Arthritis Rheum (2011) 1.78
A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies. Kidney Int (2011) 1.77
Susac's syndrome: 1975-2005 microangiopathy/autoimmune endotheliopathy. J Neurol Sci (2007) 1.76
Activation of the Nrf2/antioxidant response pathway increases IL-8 expression. Eur J Immunol (2005) 1.74
Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford) (2011) 1.70
Increased sensitivity of the European medicines agency algorithm for classification of childhood granulomatosis with polyangiitis. J Rheumatol (2012) 1.70
Measuring process of arthritis care: the Arthritis Foundation's quality indicator set for rheumatoid arthritis. Semin Arthritis Rheum (2006) 1.69
A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet (2011) 1.68
The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet Med (2009) 1.68
Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting. Arthritis Rheum (2007) 1.66
Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma. Nat Clin Pract Nephrol (2007) 1.63
Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U S A (2010) 1.63
Optimizing measurement of self-reported adherence with the ACTG Adherence Questionnaire: a cross-protocol analysis. J Acquir Immune Defic Syndr (2007) 1.62
A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap. PLoS Genet (2011) 1.62
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol (2014) 1.62
Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract (2010) 1.62
Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol (2009) 1.57
Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes. PLoS Genet (2011) 1.57
Tolerating increases in the serum creatinine following aggressive treatment of chronic kidney disease, hypertension and proteinuria: pre-renal success. Am J Nephrol (2012) 1.57
Association of tumor necrosis factor alpha polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort. Arthritis Rheum (2006) 1.55
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. Arthritis Res Ther (2009) 1.54
Ozone enhances markers of innate immunity and antigen presentation on airway monocytes in healthy individuals. J Allergy Clin Immunol (2007) 1.54
Inflammasome mRNA expression in human monocytes during early septic shock. Am J Respir Crit Care Med (2008) 1.52
Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int (2008) 1.51
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum (2011) 1.51
Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet (2011) 1.49
Respiratory symptoms among HIV-seropositive individuals. Chest (2003) 1.49
Genetic sophistication of human complement components C4A and C4B and RP-C4-CYP21-TNX (RCCX) modules in the major histocompatibility complex. Am J Hum Genet (2002) 1.47
A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus. Hum Mol Genet (2008) 1.43
Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. Am J Hum Genet (2010) 1.43
Cardiac teratogenicity in mouse maternal phenylketonuria: defining phenotype parameters and genetic background influences. Mol Genet Metab (2012) 1.41
Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Ann Rheum Dis (2011) 1.41
Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am J Hum Genet (2012) 1.41
Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus. Kidney Int (2005) 1.40
Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol (2005) 1.37
Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum (2009) 1.37
The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures. J Rheumatol (2009) 1.35
Recent insights into the genetic basis of systemic lupus erythematosus. Ann Rheum Dis (2012) 1.35
Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference. Arthritis Care Res (Hoboken) (2010) 1.32
Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum (2012) 1.32
An unusual cause of gross hematuria and transient ARF in an SLE patient with warfarin coagulopathy. Am J Kidney Dis (2004) 1.31
Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index. Arthritis Rheum (2009) 1.30
Energy expenditure estimated by accelerometry and doubly labeled water: do they agree? Med Sci Sports Exerc (2006) 1.29
Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. J Rheumatol (2003) 1.28
Systemic lupus erythematosus genome scan: support for linkage at 1q23, 2q33, 16q12-13, and 17q21-23 and novel evidence at 3p24, 10q23-24, 13q32, and 18q22-23. Arthritis Rheum (2004) 1.27
Pulmonary manifestations of the antiphospholipid antibody syndrome. Clin Chest Med (2010) 1.26
A dinucleotide deletion in CD24 confers protection against autoimmune diseases. PLoS Genet (2007) 1.25
Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice? Clin J Am Soc Nephrol (2012) 1.25
Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities, and body mass index. J Immunol (2003) 1.24